Profitelligence Profitelligence · Filing Ledger Open A research →

Form 8-K · Current Report · Filed 2024-12-13

Agilent Technologies Reorganizes Operational Structure

Agilent Technologies, Inc. announced a reorganization of its operational structure into three new reportable segments: life sciences and diagnostics markets, applied markets, and Agilent CrossLab. This restructuring will be reflected in the company's financial statements starting from the quarter ending January 31, 2025, with prior periods recast accordingly. The unaudited segment information for the past fiscal years and quarters is provided as an exhibit to this report.

Filer
Agilent Technologies Inc. A · NYSE
Filed
Accession
0001090872-24-000045
CIK
0001090872
Signal
Low impactHealthcare

Items reported

Item 7.01

Regulation FD Disclosure

Regulation FD Disclosure
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$140.91

Next session

-2.3%

Since filing

-1.8%

Latest close

$138.37

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from A reporting the same item, with the next session's move:

Exhibits (1)

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another A filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts